临床研究
左心室舒张功能不全在透析病人评估小说散斑跟踪应变率分析:患病率和决定因素
表1
基线人口总病人的临床特点和分裂的存在
或不
重要的左心室舒张功能不全。
|
|
所有患者() |
() |
() |
|
| 年龄(岁)。 |
|
|
|
| 男性的性别 |
57 (74.0%) |
28 (70.0%) |
29 (78.4%) |
| 血液透析 |
46 (59.7%) |
19 (47.5%) |
27 (73.0%)* |
| 透析年份(个月) |
16 |
12 |
21 |
| NYHA类 |
|
|
|
| 我 |
52 (68.5%) |
30 (75.0%) |
22 (59.5%) |
| II / III |
25 (31.5%) |
10 (25.0%) |
15 (40.5%) |
| 高血压 |
67例(87.0%) |
31 (77.5%) |
36 (97.3%)* |
| BSA |
|
|
|
| 糖尿病 |
24 (31.2%) |
8 (20.0%) |
16 (43.3%)* |
| 心肌梗死 |
21 (27.3%) |
9 (22.5%) |
12 (32.4%) |
| 血红蛋白(更易/ L) |
|
|
|
| 肌酐(μ摩尔/升) |
|
|
|
| 钙(更易/ L) |
|
|
|
| 磷酸(更易/ L) |
|
|
|
| β拦截器 |
43 (55.8%) |
22 (55.0%) |
21 (56.8%) |
| ACEI / ARB |
41 (53.2%) |
22 (55.0%) |
19 (51.4%) |
| 他汀类药物 |
55 (71.4%) |
28 (70.0%) |
27 (72.3%) |
| 采集(米/秒) |
|
|
* |
|
|
*患者之间和患者。 ACEI / ARB:血管紧张素转换酶抑制剂或受体阻滞剂;BSA:身体表面积;NYHA:纽约心脏协会;采集:脉搏波速度。
|